A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II–IVa Nasopharyngeal Carcinoma.

MLA

Yang, Kaixuan, et al. “A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II–IVa Nasopharyngeal Carcinoma.” Frontiers in Oncology, vol. 12, Sept. 2021, pp. 1–10. EBSCOhost, https://doi.org/10.3389/fonc.2021.640077.

APA

Yang, K., Zhang, Q., Zhang, M., Xie, W., Li, M., Zeng, L., Wang, Q., Zhao, J., Li, Y., & Li, G. (2021). A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II–IVa Nasopharyngeal Carcinoma. Frontiers in Oncology, 12, 1–10. https://doi.org/10.3389/fonc.2021.640077

Chicago

Yang, Kaixuan, Qian Zhang, Mengxi Zhang, Wenji Xie, Mei Li, Lei Zeng, Qiang Wang, Jianling Zhao, Yiping Li, and Guangjun Li. 2021. “A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II–IVa Nasopharyngeal Carcinoma.” Frontiers in Oncology 12 (September): 1–10. doi:10.3389/fonc.2021.640077.